Open AccessClinical study of Arogyavardhini compound and lifestyle modification in management of metabolic syndrome: A double-blind placebo controlled randomized clinical trial
Author(s) -
Bharatkumar Chhaganbhai Padhar,
Alankruta R Dave,
Mandip Goyal
Publication year - 2019
Publication title -
ayu
Language(s) - English
Resource type - Journals
eISSN - 0976-9382
pISSN - 0974-8520
DOI - 10.4103/ayu.ayu_79_19
Subject(s) - medicine , waist , blood pressure , hypertriglyceridemia , metabolic syndrome , obesity , insulin resistance , lifestyle modification , randomized controlled trial , placebo , management of obesity , endocrinology , physical therapy , weight loss , triglyceride , cholesterol , alternative medicine , pathology
Metabolic syndrome (MS) is a cluster of obesity, hypertriglyceridemia, impaired glucose tolerance, and insulin resistance. The sedentary lifestyle settles on the phenotypical expression of a genetically acquired trait in an obese person. Weight control and a healthy lifestyle remain primary and effective strategies for prevention and management of the MS. The lifestyle modifications mentioned for Santarpanjanya (disorders due to over nutrition) diseases and Arogyavardhini compound that can improve metabolism and reduce weight were selected for a present clinical trial to assess and compare their efficacy in the management of the MS.